A biobank can be defined as an organized and programed storage of biological materials and corresponding data that can be used in healthcare research. The biological samples vital for medical innovation include tissue, body fluids (such as serum, blood, urine, or fluids from punctures), related derivatives (RNA, DNA, or proteins), and cells.

As biobanks help in providing personalized medications and minimizing drug side effects, thereby improving the overall health of patients suffering from various diseases, the demand for biobanks will augment worldwide. Some of the key factors driving the market for biobanks are advancement in drug discovery, rising prevalence of chronic disorders such as cancer, respiratory disorders, and cardiovascular diseases, increasing healthcare expenditure, and several government initiatives supporting the development of biobanks. Another growth driver of the global biobanks market is the gradual propagation of awareness about biobanks and their significance.
In 2018, the global Biobanks market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biobanks status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biobanks development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific (US)
Tecan Group (Switzerland)
Qiagen (Germany)
Hamilton (US)
Brooks Automation (US)
TTP Labtech (UK)
VWR (US)
Promega (US)
Worthington Industries (US)
Chart Industries (US)
Becton Dickinson (US)
Merck (Germany)
Micronic (Netherlands)
LVL Technologies (Germany)
Panasonic Healthcare (Japan)
Greiner Bio One (Greiner Holding AG, Austria)
Biokryo (Germany)
Biobank (Norway)
Biorep Technologies (US)
Cell & Co Bioservices (France)
RUCDR infinite biologics (US)
Modul-Bio (France)
CSols (UK)
Ziath (UK)
LabVantage Solutions (US)

Market segment by Type, the product can be split into
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids
Human Waste Products

Market segment by Application, split into
Regenerative Medicine
Life Science Research
Clinical Research

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biobanks status, future forecast, growth opportunity, key market and key players.
To present the Biobanks development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biobanks are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.